2016 - Contraceptive Technology Boston

Apr 24, 2016 ‐ Apr 27, 2016


Total CE Credits:
76.00 - Physician
76.00 - RN / NP (All RNs/Nurses except CA RNs)
76.00 - CA RN/CA BRN
19.50 - Pharmacology


The changing medical and policy climates continue to challenge reproductive health care providers, as we work at keeping our focus on providing high quality, evidence-based care for our patients. The 2016 online conference features current research as well as recent and future developments in contraceptive technology. You’ll learn how to develop strategies for approaching a variety of contraceptive management challenges, including adolescent issues, IUD complications, bleeding problems, and chronic medical conditions. Our outstanding faculty also addresses a variety of gynecologic conditions in women - vulvar disease, recurrent vaginitis and heavy menstrual bleeding. You’ll learn screening techniques along with clinical management of common and complex challenges in women's health and primary care, including STDs, obesity, sexual pharmacology, vulvar dermatology, depression and other current topics.

Program Manager:

Donna Brian PhD, CRNP
Consultant
Contemporary Forums

Disclosures: The Program Manager has nothing to disclose

Standard: $912.00

Sessions

What's Hot in the 2015 CDC STD Treatment Guidelines (Rx = .5 hr.)

Apr 24, 2016 1:15pm ‐ Apr 24, 2016 1:45pm
Expiration Date: May 12, 2019

Credits: None available.

Learning Objectives:

  • Focus on incorporating the 2015 recommendations for screening and re-screening for STIs
  • Emphasize improvement in diagnostic testing and treatment for STIs
  • Download the 2015 CDC STD Treatment Guidelines App for smartphone use at the point of care

Speaker(s):
Standard: $12.00

The Vagina Dialogues (Rx = .5 hr.)

Apr 24, 2016 1:45pm ‐ Apr 24, 2016 2:30pm
Expiration Date: May 12, 2019

Credits: None available.

Learning Objectives:

  • Describe the most common etiologies of vaginitis
  • State the clinical and laboratory criteria for the diagnosis of trichomoniasis, BV, and candidiasis
  • Discuss the clinical management of vaginitis to include treatment, follow-up, patient counseling and partner management

Speaker(s): Disclosures
  • Caroline Mitchell, MD, MPH:

    Disclosure:

    Perrigo Pharmaceuticals

    Relationship:

    Advisory Board Member

Standard: $15.00

Warts and All: Prevention and Screening for HPV-Related Disease, Including Guidance on the HPV9 Phase-In

Apr 24, 2016 2:30pm ‐ Apr 24, 2016 3:15pm
Expiration Date: May 12, 2019

Credits: None available.

Learning Objectives:

  • Describe national recommendations for HPV vaccination
  • Discuss counseling messages for patients diagnosed with HPV or abnormal Pap tests
  • Discuss new proposed algorithm for HPV primary screening for cervical cancer

Speaker(s):
Standard: $15.00

Something's Wrong Down Under: Cervicitis/Urethritis/PID (Rx = .5 hr.)

Apr 24, 2016 3:30pm ‐ Apr 24, 2016 4:15pm
Expiration Date: May 12, 2019

Credits: None available.

Learning Objectives:

  • Discuss updates to CDC STD guidelines for diagnosis and treatment of cervicitis and urethritis-related diseases
  • Discuss diagnosis and treatment of antibiotic-resistant gonorrhea
  • Discuss screening guidelines for chlamydia and gonorrhea

Speaker(s):
Standard: $15.00

STD Clinical Pearls: Challenging Cases (Rx = .75 hr.) - Q&D (Rx = .25 hr.) - Faculty Panel

Apr 24, 2016 4:15pm ‐ Apr 24, 2016 5:30pm
Expiration Date: May 12, 2019

Credits: None available.

Speaker(s): Disclosures
  • Erica Hardy, MD, MMSc:

    Erica Hardy, MD

    Disclosure:

    This speaker has nothing to disclose

  • Katherine Hsu, MD, MPH, FAAP:

    Katherine Hsu, MD, MPH, FAAP

    Disclosure:

    This speaker has nothing to disclose

  • Caroline Mitchell, MD, MPH:

    Caroline Mitchell, MD, MPH

    Disclosure:

    Perrigo Pharmaceuticals

    Relationship:

    Advisory Board Member

  • Rachel Epstein, MD, MPH:

    Rachel Epstein, MD, MPH

    Disclosure:

    This speaker has nothing to disclose

Standard: $21.00

Program Overview & ObjectivesProgram Overview & Objectives

Preview Available

Program Overview & Objectives

Apr 25, 2016 8:00am ‐ Apr 25, 2016 8:15am
Expiration Date: May 12, 2019

Credits: None available.

Speaker(s): Disclosures
  • Robert Hatcher, MD, MPH:

    Robert A. Hatcher, MD, MPH

    Disclosure:

    This speaker has nothing to disclose

  • Deborah Kowal, MA, PA:

    Deborah Kowal, MA, PA

    Disclosure:

    This speaker has nothing to disclose

Standard: $7.50

Cervical Cancer Screening Update & Implications for Annual Pelvic Exams

Apr 25, 2016 8:15am ‐ Apr 25, 2016 8:45am
Expiration Date: May 12, 2019

Credits: None available.

Learning Objectives:

  • Describe the latest cervical cancer screening guidelines (updated in 2012 and 2016)
  • Discuss areas of existing controversy
  • Describe potential new applications for HPV testing as a primary screen

Speaker(s):
Standard: $12.00

The Skinny on Weight and Birth Control (Rx = .25 hr.)

Apr 25, 2016 8:45am ‐ Apr 25, 2016 9:15am
Expiration Date: May 12, 2019

Credits: None available.

Learning Objectives:

  • Be familiar with the current evidence regarding obesity and its impact on contraception
  • Identify effective contraceptive methods for women of varying weight
  • Review the potential impact of contraception on weight gain

Speaker(s): Disclosures
  • Anne Burke, MD, MPH:

    Disclosure:

    HRA Pharma
    Leon Pharma
    Bayer

    Relationship:

    Data Safety Monitoring Board
    Research Support
    Research Support

Standard: $12.00

Understanding and Communicating Risk of Hormonal Contraception with a Special Focus on VTE (Rx = .25 hr.)

Apr 25, 2016 9:15am ‐ Apr 25, 2016 9:45am
Expiration Date: May 12, 2019

Credits: None available.

Learning Objectives:

  • Assess factors that influence patients’ perceptions of risk
  • Define absolute risk, attributable risk, relative risk, and odds ratio
  • Explain the advantages and disadvantages of different study designs for assessing the risk of VTE from use of hormonal contraceptives

Speaker(s):
Standard: $12.00

Adolescent Contraception (Rx = .5 hr.)

Apr 25, 2016 10:15am ‐ Apr 25, 2016 11:00am
Expiration Date: May 12, 2019

Credits: None available.

Learning Objectives:

  • Consider the developmental, socioecological and other factors influencing an adolescent's contraceptive choices and use
  • Incorporate key elements for delivering teen friendly care
  • Optimize contraceptive counseling and management for adolescent patients

Speaker(s): Disclosures
  • Melissa Kottke, MD, MPH:

    Disclosure:

    Merck
    CSL Behring

    Relationship:

    Faculty Trainer
    Consultant

Standard: $15.00
Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content
token-speaker-name image
token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content